Despite weight loss and glycemic control, experts caution that type 2 diabetes remission is not a cure and that pancreatic ...

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...

Further, it is also an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...

Bei der Verarbeitung der Anfrage ist ein technischer Fehler aufgetreten ...

Eli Lilly says it is a first-of-its-kind treatment for obesity, overweight, and type 2 diabetes that activates both GIP and ...

Eli Lilly launched Mounjaro, a weight-loss injectable, in India, priced at ₹4,375 for 5 mg, targeting obesity and type-2 diabetes management.

Weekly payments will increase to either £73.90 (lower rate) or £110.40 (higher rate) from April 7. This benefit, which is not ...

Pharma giant Eli Lilly has launched Mounjaro, a popular weight-loss drug, in India. Priced at Rs 3,500 for 2.5 mg and Rs ...

Of course, any exercise is better than none, and that can include swimming, yoga, cycling and more, but there’s one that ...

City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States and a top ...

A new study explores how a brief psychoeducational intervention for parents may help prevent disordered eating in children ...